H2020Съфинансиране2017–2022

GenomMed · Genomics and Mechanisms in Translational Medicine Doctoral Programme

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период: 2017-04-01 → 2022-12-31
Финансиране от ЕС: 1 255 680 €
Участници: 1
Схема: MSCA-COFUND

Линиите свързват координатора с партньорите.

Накратко на български

Геномните механизми при сърдечно-съдови, метаболитни и неврологични заболявания, като диабет тип 2 и болест на Алцхаймер, се анализират чрез „омикс“ технологии. Това помага за подобряване на превенцията, диагностиката и лечението на тези състояния.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Genomics and Mechanisms in Translational Medicine Doctoral Programme

European and global health care is faced with a growing burden of major age-associated diseases such as cardiovascular and metabolic diseases (including type 2 diabetes and obesity) and neurological diseases (including Alzheimer’s disease, traumatic brain injury, and post-traumatic epilepsy). The objective of research in this doctoral program was to produce internationally significant findings which affect the prevention, diagnostics and treatment of the diseases studied, and which support cooperation between the university and businesses and the emergence of new companies. New means of diagnosis and treatment are needed to survive the challenges in health care. Genomics focuses on utilizing –“omics” technologies, such as genetics, transcriptomics, epigenetics, proteomics and metabolomics approaches to study genomics in an integrative manner. These methods were used to perform target and pathway analysis to identify key genomic mechanisms relevant to cardiovascular and metabolic diseases and neurosciences. The objective of the GenomMed doctoral program was to train international experts • who aim to solve health care -related questions in cardiovascular and metabolic diseases and neurosciences, • who are wanted in the European job market, and • who are future research leaders in translational genomics. The aim of the program was that the graduates of GenomMed are wanted employees in Europe at all career stages, thereby strengthening the human capital in Europe and increasing its competitiveness and attractiveness as a business location on global scale.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

The GenomMed programme will train international experts who are wanted in the European job market and future research leaders in translational genomics. These experts aim to solve health care -related questions in cardiovascular and metabolic diseases and neurosciences. They will have skills to create solutions and innovations to develop novel treatments in the European and global environment. Health care is globally faced with a growing burden of major age-associated diseases. New means of diagnosis and treatment are needed to survive the challenges.This will be gained by offering world class research-oriented PhD training in genomics, cardiovascular and metabolic diseases, neurosciences, and clinical adaptation of research results. In depth knowledge and methodology training will be topped up with well-planned transferable skills curricula providing the graduates with skills needed in changing career paths after their initial researcher training. Other means to achieve training goals include well-planned mobility periods to international collaborators’ research environments, meaningful secondments at intersectoral partners’ projects, and frequent exposure to interdisciplinary activities between the participating research groups.The GenomMed Doctoral Programme will take the researcher training to the next level in terms of research excellence, productive international and intersectoral mobility, and interdisciplinary exposure. Graduates will gain a unique set of research and transferable skills. Career development is a built-in feature of the training leading to increased employability of graduates in and outside academia and enhanced R&I input for the European economy and society. In pursuance of better trained PhDs, HR practices of hosting institutions will be developed and harmonized, and intersectoral collaboration will become regular. Furthermore mobility schemes at system level will develop and become part of everyday actions in research organizations.

Оригинален текст от CORDIS (на английски).

Участници

ITA-SUOMEN YLIOPISTO · KUOPIOКоординаторФинландия